Exploring alternatives to plasmid DNA for safer, higher quality gene therapy

David McCall, Senior Editor, BioInsights, speaks with Nafiseh Nafissi, Chief Technology Officer, Mediphage Bioceuticals, about the applications and advantages of ministring DNA, including as the basis for a novel gene therapy modality.

Please enter your email to access content Read now